REGENASYN Trademark

Trademark Overview

On Friday, April 22, 2011, a trademark application was filed for REGENASYN with the United States Patent and Trademark Office. The USPTO has given the REGENASYN trademark a serial number of 85302639. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 8, 2014. This trademark is owned by Synedgen, Inc.. The REGENASYN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical compound to prevent and stimulate the healing of oral and ophthalmic injuries or lesions
regenasyn

General Information

Serial Number85302639
Word MarkREGENASYN
Filing DateFriday, April 22, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 8, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2011

Trademark Statements

Goods and Servicespharmaceutical compound to prevent and stimulate the healing of oral and ophthalmic injuries or lesions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 26, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSynedgen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressClaremont, CA 91711
Party NameSynedgen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressClaremont, CA 91711

Trademark Events

Event DateEvent Description
Monday, December 8, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 8, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, March 12, 2014EXTENSION 5 GRANTED
Tuesday, March 11, 2014EXTENSION 5 FILED
Tuesday, March 11, 2014TEAS EXTENSION RECEIVED
Tuesday, August 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, August 19, 2013EXTENSION 4 GRANTED
Friday, August 16, 2013EXTENSION 4 FILED
Friday, August 16, 2013TEAS EXTENSION RECEIVED
Thursday, February 14, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, February 13, 2013EXTENSION 3 GRANTED
Tuesday, February 12, 2013EXTENSION 3 FILED
Tuesday, February 12, 2013TEAS EXTENSION RECEIVED
Saturday, November 3, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, November 2, 2012EXTENSION 2 GRANTED
Monday, October 29, 2012EXTENSION 2 FILED
Friday, November 2, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 29, 2012TEAS EXTENSION RECEIVED
Saturday, April 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, April 12, 2012EXTENSION 1 GRANTED
Thursday, April 12, 2012EXTENSION 1 FILED
Thursday, April 12, 2012TEAS EXTENSION RECEIVED
Tuesday, November 1, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 6, 2011PUBLISHED FOR OPPOSITION
Wednesday, August 17, 2011NOTICE OF PUBLICATION
Monday, August 1, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 1, 2011ASSIGNED TO EXAMINER
Tuesday, April 26, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 26, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

regenasyn ophthalmic injuries lesions oral healing compound prevent stimulate pharmaceutical